{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:51:20Z","timestamp":1786989080167,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.exppara.2020.107834","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T02:19:08Z","timestamp":1579573148000},"page":"107834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon"],"prefix":"10.1016","volume":"210","author":[{"given":"Lu\u00edsa","family":"Perin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia da Silva","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Vieira","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Mendes","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vitor","family":"Madeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana da Fonseca","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Correa-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Martins","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Melo de Abreu","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2020.107834_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002907","article-title":"Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults","volume":"8","author":"Altcheh","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2020.107834_bib2","first-page":"833","article-title":"New scheme of intermittent benznidazole administration in patients chronically infected with trypanosoma cruzi\u00a0: a pilot short-term follow-up study with adult","volume":"60","author":"\u00c1lvarez","year":"2016","journal-title":"Patients"},{"key":"10.1016\/j.exppara.2020.107834_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.trstmh.2012.07.010","article-title":"Transactions of the Royal Society of tropical medicine and hygiene seronegative conversion after incomplete benznidazole treatment in chronic chagas disease","volume":"106","author":"\u00c1lvarez","year":"2012","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2020.107834_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/45.6.819","article-title":"A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease","volume":"45","author":"Araujo","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128707","article-title":"Benznidazole\/itraconazole combination treatment enhances anti-trypanosoma cruzi activity in experimental chagas disease","volume":"10","author":"Ass\u00edria Fontes Martins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2020.107834_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001870","article-title":"Fexinidazole: a potential new drug candidate for chagas disease","volume":"6","author":"Bahia","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2020.107834_bib7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/13543784.2014.922952","article-title":"Therapeutical approaches under investigation for treatment of Chagas disease","volume":"23","author":"Bahia","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.exppara.2020.107834_bib8","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1128\/AAC.02754-13","article-title":"Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas disease","volume":"58","author":"Bahia","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib9","article-title":"Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo","volume":"6","author":"Batista Dda","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2020.107834_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2307\/3277711","article-title":"Comparison of infectivity of strains of Trypanosoma cruzi (Chagas, 1909)","volume":"56","author":"Bice","year":"1970","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2020.107834_bib11","doi-asserted-by":"crossref","DOI":"10.1590\/S0074-02761993000100030","article-title":"A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease","author":"Britto","year":"1993","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2020.107834_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jit420","article-title":"New, combined, and reduced dosing treatment protocols cure trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2020.107834_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijantimicag.2012.08.002","article-title":"Evaluation of benznidazole treatment combined with nifurtimox , posaconazole or AmBisome \u00ae in mice infected with Trypanosoma cruzi strains","volume":"40","author":"Cencig","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2020.107834_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","article-title":"Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain","volume":"6","author":"Cevey","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2020.107834_bib15","doi-asserted-by":"crossref","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana. Estudo sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2020.107834_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.exppara.2020.107834_bib17","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.2147\/DDDT.S90208","article-title":"Translational challenges of animal models in chagas disease drug development: a review","volume":"9","author":"Chatelain","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.exppara.2020.107834_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Coura","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2020.107834_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S0074-02762011000600001","article-title":"Chronic phase of Chagas disease: why should it be treated? A comprehensive review","volume":"106","author":"Coura","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2020.107834_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR","volume":"129","author":"Cummings","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2020.107834_bib21","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1128\/AAC.00178-16","article-title":"Efficacy of lychnopholide polymeric nanocapsules after oral and intravenous administration in murine experimental chagas disease","volume":"60","author":"de Mello","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib22","doi-asserted-by":"crossref","first-page":"e2367","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"Diniz Lde","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2020.107834_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.exppara.2008.09.007","article-title":"Trypanosoma cruzi: induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection","volume":"120","author":"dos Santos","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2020.107834_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0037-86822007000100001","article-title":"Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution","volume":"40","author":"Fabbro","year":"2007","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.exppara.2020.107834_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2020.107834_bib26","first-page":"1","article-title":"Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage","author":"Francisco","year":"2016","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.exppara.2020.107834_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00832-18","article-title":"Assessing the effectiveness of curative benznidazole treatment in preventing chronic cardiac pathology in experimental models of chagas disease","volume":"62","author":"Francisco","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0001-706X(02)00139-0","article-title":"The dog as model for chemotherapy of the Chagas' disease","volume":"84","author":"Guedes","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2020.107834_bib29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/cmi.12297","article-title":"Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection","volume":"16","author":"Lewis","year":"2014","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.exppara.2020.107834_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bcp.2018.01.005","article-title":"Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: a pre-clinical study","volume":"148","author":"Mazzeti","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2020.107834_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2307\/3279787","article-title":"Tissue tropism of different Trypanosoma cruzi strains","volume":"64","author":"Melo","year":"1978","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2020.107834_bib32","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1128\/AAC.04660-14","article-title":"Toxic profile of benznidazole in patients with chronic chagas disease: risk factors and comparison of the product from two different manufacturers","volume":"59","author":"Molina","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/46.1.137","article-title":"In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi","volume":"46","author":"Molina","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (Posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib35","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/AAC.02531-12","article-title":"Modulation of biotransformation systems and ABC transporters by benznidazole in rats","volume":"57","author":"Perdomo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"In vitro and in vivo experimental models for drug screening and development for Chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2020.107834_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","article-title":"Experimental and clinical treatment of Chagas disease: a review","volume":"97","author":"Sales","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2020.107834_bib38","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/AAC.05018-14","article-title":"Population pharmacokinetics of benznidazole in adult patients with Chagas disease","volume":"59","author":"Soy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.107834_bib39","series-title":"Working to Overcome the Global Impact of Neglected Tropical Diseases First WHO Report on Neglected Tropical Diseases","year":"2010"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941930503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941930503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:26:17Z","timestamp":1758003977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448941930503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":39,"alternative-id":["S001448941930503X"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2020.107834","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2020.107834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107834"}}